LinkedIn YouTube Bluesky
Search
English / Français
Ethics Portal
LinkedIn YouTube Bluesky
Search
English / Français
Ethics Portal
  • Who We Are
    • About Us
    • Business Model
    • Our Strategy 2023-2025
    • Statutes, By-Laws & Policies
    • Governance & Team
    • Annual Reports
    • Careers & RFPs
  • What We Do
    • Licensing for Public Health
    • MRNA Technology Transfer Programme
    • Disease Areas
    • Focus areas
      • Biotherapeutics
      • Local and Regional Manufacturing
      • Pandemic Preparedness and Response
      • Upstream Access
      • Technology Transfer
    • Addressing Children's Needs
    • Patent Information Tools
      • MedsPaL
      • LAPaL
    • Long-Acting Therapeutics
  • Progress
    • Prioritisation
    • Agreements with Innovators
    • Access to Medicines Tracker
    • Contribution to Universal Health Coverage
    • Endorsements
    • Impact
  • News & Publications
    • News, Events & Press Releases
    • Messages from the Executive Director
    • MPP in the Media
    • MPP Publications
    • Related Publications
    • Newsletters & Updates
  • Partners
    • Partnering with MPP
    • Our Stories
      • Voices from Friends of MPP
      • Voices from the Frontline
      • I am part of the DTG story
    • Funders
    • How to Give or Get a Licence
  • Contact Us
news & publications » MPP Publications

MPP Prioritisation Reports – Archives

1 July 2020

  • 2024 Prioritisation Report
  • 2023 Prioritisation Report
  • 2022 Prioritisation Report
  • 2021 Prioritisation Report
  • 2020 Prioritisation Report
  • 2019 Prioritisation Report
  • 2018 Prioritisation Report
  • Annex to the 2018 Prioritisation Report: HIV and HCV pipelines compiled by the MPP
  • 2017 Prioritisation Report: Prioritisation of HIV and Hepatitis C medicines for in-licensing by the Medicines Patent Pool
  • 2015 Prioritisation Report: Antiretroviral priorities of the Medicines Patent Pool – 4th Edition
  • 2013 Prioritisation Report Priority Antiretrovirals for the Medicines Patent Pool – 3rd Edition (December 2013)
  • 2012 Prioritisation Report
  • 2011 Prioritisation Report
Share page:
Facebook
Linkedin
Bluesky

Contact Us

Science

Related page

Prioritising Medicines for Licensing

MPP Logo

Subscribe to our Newsletter

Subscribe to our Newsletter

Subscribe

* indicates required






The Medicines Patent Pool will use the information (email address) you provide on this form to be in touch with you and to provide updates.


You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at press@medicinespatentpool.org. We will treat your information with respect. For more information about our privacy practices, please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices here.


About Us
Licences
MedsPaL
Careers & RFPs
Privacy Policy
Contact

Founded & funded by

Unitaid Logo

Other funders